Speaker: 

Varun R Pulakanti, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss role for empirical anticoagulation for cryptogenic study.
• Discuss the potential role atrial cardiopathy plays in cardioembolic risk.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD; Laura Fierke, PA-C and Lisa Wasko, BSN RN SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.